Januvia

For Merck, Three Out Of Four Ain’t Bad

Make a comment

Merck’s Januvia Is Hot: Survey

1 Comment

Another Merck Diabetes Pill On Its Way

Make a comment

Never Mind Vioxx, Here’s Januvia!

Make a comment

Where There’s Smoke, There’s Chantix

Make a comment

For Merck’s Januvia, The Sky Is The Limit

1 Comment

Bad News for Novartis: Galvus Delayed, Again

Make a comment

Novartis’ Galvus May Be Delayed: Analyst

4 Comments

Exubera Bounces Back, Januvia Surges

Make a comment

Rx Trends: Who’s Up, Who’s Down

Make a comment

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/

-->